We then explored the circulating levels of SDC4 in a cohort of patients with type 2 diabetes (T2D), a prototypical ARD that is linked with the accrual of senescent endothelial cells [29] and exhibits a circulating signature that mirrors many of the hallmarks of aging and senescence [35, 39, 41]. Here, SDC4 is linked to type 2 diabetes mellitus.